AKT1 and type 2 diabetes mellitus: The miR-27a is reportedly involved in insulin resistance and glucose metabolism via the PPAR-γ-mediated PI3K/Akt signaling pathway, and miR-27a is a potential target for decreasing insulin resistance and sugar metabolism in T2D [21].